CD8A and cancer: Recently, our group found that IL-18 receptor signaling in intratumoral CD8+ T cells promotes impaired tumor rejection, the increased expression of coinhibitory receptors, and the loss of cytotoxic cytokine production in a murine subcutaneous PancOVA and orthotopic KPC tumor model (Lutz et al., Cancer Immunology Research, in press).